Case Report
BibTex RIS Cite

TANISI KONULAMAYAN/ATLANAN MEME KANSERİNDE DRAMATİK BİR CERRAHİ TEKNİK: TUVALET MASTEKTOMİ

Year 2024, , 172 - 176, 01.01.2024
https://doi.org/10.53394/akd.1138846

Abstract

Metastatik meme kanserinde tedavi seçenekleri sınırlıdır ve genel yaklaşım sistemik kemoterapi ile tedavidir. Ancak günümüzde ileri evre meme kanserli hastaların yaşam süreleri hedefe yönelik tedaviler ile uzatılabilmektedir. Tuvalet mastektomi adı verilen primer tümörün cerrahi tedavisi, kanamalı, enfeksiyonlu ve deri tutulumu olan ilerlemiş meme kanseri durumlarında kaçınılmazdır. Bu olgu sunumunda ileri evre meme kanserli ve tuvalet mastektomi yapılan bir hastanın tanı ve tedavi sürecinin sunulması amaçlanmaktadır.

References

  • 1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209-49.
  • 2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72(1):7-33.
  • 3. Schünemann HJ, Lerda D, Quinn C, et al. Breast cancer screening and diagnosis: a synopsis of the European Breast Guidelines. Ann Intern Med 2020;172(1):46-56.
  • 4. Constantin A, Predescu D, Ciofu R, Achim F, Constantinoiu S. Palliative “Toilet” Mammectomy, A Decision-Making Dilemma-Short Review. Chirurgia 2021;116(2):150-61.
  • 5. Özmen V, Özmen T, Doğru V. Breast cancer in Turkey; an analysis of 20.000 patients with breast cancer. Eur J Breast Health 2019;15(3):141-6.
  • 6. DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin 2019;69(6):438-51.
  • 7. Siegel RL, Miller KD, Jemal A et al. Cancer statistics, 2015. CA Cancer J Clin 2015;65(1):5-29.
  • 8. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 2006;56(1):37-47.
  • 9. Manzoor S, Anwer M, Soomro S, Kumar D. Presentation, diagnosis and management of locally advanced breast cancer: Is it different in low/middle income countries? Pak J Med Sci 2019;35(6):1554-7.
  • 10. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 2002;132(4):620-7.
  • 11. Fields RC, Jeffe DB, Trinkaus K, et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol 2007;14(12):3345-51.
  • 12. Ahmad HH, Nicolas G, Saliba C, et al. Chest wall reconstruction with a bilayered wound matrix mesh following toilet mastectomy. Am J Case Rep 2019;20:1736-9.
  • 13. Dharkar DV, Moses S. Palliative mastectomy revisited. Indian J Palliat Care. 2018;24:359-361.

A DRAMATIC SURGICAL TECHNIQUE FOR A MIS (UN)DIAGNOSED BREAST CANCER: TOILET MASTECTOMY

Year 2024, , 172 - 176, 01.01.2024
https://doi.org/10.53394/akd.1138846

Abstract

Treatment options in metastatic breast cancer are limited, and the general approach is treatment with systemic chemotherapy. However, today, the survival of patients with advanced-stage breast cancer can be extended with targeted therapies. Surgical treatment of the primary tumour called toilet mastectomy is inevitable in cases of bleeding, infection, and advanced breast cancer with skin involvement. This case report is aimed to present the diagnosis and treatment process of a patient with advanced breast cancer who underwent toilet mastectomy.

References

  • 1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209-49.
  • 2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72(1):7-33.
  • 3. Schünemann HJ, Lerda D, Quinn C, et al. Breast cancer screening and diagnosis: a synopsis of the European Breast Guidelines. Ann Intern Med 2020;172(1):46-56.
  • 4. Constantin A, Predescu D, Ciofu R, Achim F, Constantinoiu S. Palliative “Toilet” Mammectomy, A Decision-Making Dilemma-Short Review. Chirurgia 2021;116(2):150-61.
  • 5. Özmen V, Özmen T, Doğru V. Breast cancer in Turkey; an analysis of 20.000 patients with breast cancer. Eur J Breast Health 2019;15(3):141-6.
  • 6. DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin 2019;69(6):438-51.
  • 7. Siegel RL, Miller KD, Jemal A et al. Cancer statistics, 2015. CA Cancer J Clin 2015;65(1):5-29.
  • 8. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 2006;56(1):37-47.
  • 9. Manzoor S, Anwer M, Soomro S, Kumar D. Presentation, diagnosis and management of locally advanced breast cancer: Is it different in low/middle income countries? Pak J Med Sci 2019;35(6):1554-7.
  • 10. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 2002;132(4):620-7.
  • 11. Fields RC, Jeffe DB, Trinkaus K, et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol 2007;14(12):3345-51.
  • 12. Ahmad HH, Nicolas G, Saliba C, et al. Chest wall reconstruction with a bilayered wound matrix mesh following toilet mastectomy. Am J Case Rep 2019;20:1736-9.
  • 13. Dharkar DV, Moses S. Palliative mastectomy revisited. Indian J Palliat Care. 2018;24:359-361.
There are 13 citations in total.

Details

Primary Language English
Subjects Clinical Sciences
Journal Section Case Report
Authors

Tolga Kalaycı 0000-0002-6977-1757

Mustafa Yeni 0000-0003-2384-2094

Murat Kartal 0000-0003-1396-5365

Mesud Fakirullahoğlu 0000-0002-5871-5688

Salih Kara 0000-0002-7877-9064

Early Pub Date January 15, 2024
Publication Date January 1, 2024
Submission Date June 30, 2022
Published in Issue Year 2024

Cite

Vancouver Kalaycı T, Yeni M, Kartal M, Fakirullahoğlu M, Kara S. A DRAMATIC SURGICAL TECHNIQUE FOR A MIS (UN)DIAGNOSED BREAST CANCER: TOILET MASTECTOMY. Akd Tıp D. 2024;10(1):172-6.